SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4f99'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IE9_A_VDXA500_1 (VITAMIN D3 RECEPTOR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	LEU A 550 LEU A 546 SER A 406 SER A 409 CYH A 462	None	1.19A	1ie9A-4f99A: undetectable	1ie9A-4f99A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IGX_A_EPAA700_1 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	5 / 12	PHE A 414 PHE B 253 GLY A 432 ALA A 455 LEU A 461	None	0.90A	1igxA-4f99A: undetectable	1igxA-4f99A: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NH8_A_HISA289_0 (ATP PHOSPHORIBOSYLTRANSF ERASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 5	ASP A 177 LEU A 194 ALA A 200 LEU A 199	None	1.04A	1nh8A-4f99A: undetectable	1nh8A-4f99A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QCA_A_FUAA221_1 (TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	CYH A 462 PHE A 151 SER A 409 PHE A 404	None	1.14A	1qcaA-4f99A: undetectable	1qcaA-4f99A: 19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	ILE A 64 LYS A 90 LEU A 108 ILE A 173	None ADP A 601 (-2.6A) None None	0.88A	1uwjA-4f99A: 5.1	1uwjA-4f99A: 25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 11	GLY A 65 VAL A 72 ALA A 88 MET A 134 TYR A 136 LEU A 184	ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) ADP A 601 (-4.1A) ADP A 601 ( 4.9A)	0.54A	2evaA-4f99A: 21.8	2evaA-4f99A: 24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	GLY A 65 VAL A 72 ALA A 88 MET A 134 LYS A 179 ASN A 182 ASP A 196	ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) None MG A 602 ( 2.6A) MG A 602 ( 3.1A)	0.81A	2fumB-4f99A: 17.4	2fumB-4f99A: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	GLY A 65 VAL A 72 ALA A 88 MET A 134 TYR A 136 ASN A 182 ASP A 196	ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) ADP A 601 (-4.1A) MG A 602 ( 2.6A) MG A 602 ( 3.1A)	0.73A	2fumB-4f99A: 17.4	2fumB-4f99A: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 12	GLY A 65 VAL A 72 ALA A 88 MET A 134 TYR A 136 ASN A 182	ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) ADP A 601 (-4.1A) MG A 602 ( 2.6A)	0.70A	2fumC-4f99A: 16.1	2fumC-4f99A: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	GLY A 65 GLY A 67 VAL A 72 ALA A 88 MET A 134 LYS A 179 ASN A 182	ADP A 601 ( 3.8A) ADP A 601 (-3.7A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) None MG A 602 ( 2.6A)	0.93A	2fumD-4f99A: 16.0	2fumD-4f99A: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VN1_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	4 / 6	LEU A 550 SER B 251 PHE B 253 ASP B 254	None	0.99A	2vn1B-4f99A: undetectable	2vn1B-4f99A: 15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	ILE A 64 ALA A 88 LYS A 90 GLU A 104 ILE A 132 TYR A 136 LEU A 184	None ADP A 601 (-3.5A) ADP A 601 (-2.6A) None None ADP A 601 (-4.1A) ADP A 601 ( 4.9A)	0.62A	2y6oA-4f99A: 15.5	2y6oA-4f99A: 23.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YY8_B_SAMB500_0 (UPF0106 PROTEIN PH0461)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 11	HIS A 139 VAL A 72 GLY A 65 ILE A 87 ALA A 88	ADP A 601 (-4.0A) ADP A 601 (-4.0A) ADP A 601 ( 3.8A) None ADP A 601 (-3.5A)	0.98A	2yy8A-4f99A: undetectable 2yy8B-4f99A: undetectable	2yy8A-4f99A: 20.73 2yy8B-4f99A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LD6_B_KKKB602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	PHE A 197 PHE A 569 PHE A 162 ILE A 403 MET A 397	None	1.47A	3ld6B-4f99A: undetectable	3ld6B-4f99A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	LEU A 550 LEU A 546 SER A 406 SER A 409 CYH A 462	None	1.15A	3m7rA-4f99A: undetectable	3m7rA-4f99A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	VAL A 72 ALA A 88 LYS A 90 GLU A 104 ILE A 132 TYR A 136 LEU A 184	ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) None None ADP A 601 (-4.1A) ADP A 601 ( 4.9A)	0.72A	3oezB-4f99A: 14.9	3oezB-4f99A: 26.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SMT_A_ACTA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SETD3)	4f99	PROTEIN DBF4 HOMOLOG A (Homo sapiens)	3 / 3	PHE B 318 SER B 321 GLN B 323	None	0.91A	3smtA-4f99B: undetectable	3smtA-4f99B: 15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T3Z_C_9PLC501_1 (CYTOCHROME P450 2E1)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	4 / 5	PHE A 124 PHE B 338 ALA A 77 LEU A 89	None	1.16A	3t3zC-4f99A: undetectable	3t3zC-4f99A: 22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 12	ILE A 64 GLY A 67 VAL A 72 ALA A 88 LYS A 90 ASP A 196	None ADP A 601 (-3.7A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) MG A 602 ( 3.1A)	0.61A	3v5wA-4f99A: 7.4	3v5wA-4f99A: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 12	ILE A 64 VAL A 72 ALA A 88 LYS A 90 LEU A 92 ASP A 196	None ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) None MG A 602 ( 3.1A)	0.76A	3v5wA-4f99A: 7.4	3v5wA-4f99A: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AGC_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 12	VAL A 72 ALA A 88 LYS A 90 GLU A 104 LEU A 108 LEU A 184	ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) None None ADP A 601 ( 4.9A)	0.55A	4agcA-4f99A: 13.7	4agcA-4f99A: 22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	ALA A 88 LYS A 90 GLU A 104 LEU A 108 ILE A 132 HIS A 175 LEU A 184	ADP A 601 (-3.5A) ADP A 601 (-2.6A) None None None None ADP A 601 ( 4.9A)	0.63A	4c8bA-4f99A: 14.0	4c8bA-4f99A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1G_A_LNLA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	5 / 12	PHE A 414 PHE B 253 GLY A 432 ALA A 455 LEU A 461	None	0.91A	4e1gA-4f99A: undetectable	4e1gA-4f99A: 20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1G_B_LNLB701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	5 / 12	PHE A 414 PHE B 253 GLY A 432 ALA A 455 LEU A 461	None	0.92A	4e1gB-4f99A: undetectable	4e1gB-4f99A: 20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 11	VAL A 72 ALA A 88 LYS A 90 LEU A 184 ASP A 196	ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.57A	4iaaA-4f99A: 23.8	4iaaA-4f99A: 24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M6T_A_SAMA201_0 (RNA POLYMERASE II-ASSOCIATED FACTOR 1 HOMOLOG, LINKER, RNA POLYMERASE-ASSOCIATE D PROTEIN LEO1)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 4	ILE A 168 VAL A 195 VAL A 117 ARG A 167	None	1.24A	4m6tA-4f99A: undetectable	4m6tA-4f99A: 21.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 8	ILE A 64 VAL A 72 ALA A 88 ASN A 182 LEU A 184 ASP A 196	None ADP A 601 (-4.0A) ADP A 601 (-3.5A) MG A 602 ( 2.6A) ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.53A	4ogrA-4f99A: 22.1	4ogrA-4f99A: 30.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 7	GLY A 65 ALA A 88 ASN A 182 LEU A 184 ASP A 196	ADP A 601 ( 3.8A) ADP A 601 (-3.5A) MG A 602 ( 2.6A) ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.72A	4ogrE-4f99A: 17.7	4ogrE-4f99A: 30.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 9	ILE A 64 VAL A 72 ALA A 88 ASN A 182 LEU A 184 ASP A 196	None ADP A 601 (-4.0A) ADP A 601 (-3.5A) MG A 602 ( 2.6A) ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.58A	4ogrI-4f99A: 24.5	4ogrI-4f99A: 30.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	ILE A 64 ALA A 88 GLU A 104 ILE A 132 TYR A 136 LEU A 184 ASP A 196	None ADP A 601 (-3.5A) None None ADP A 601 (-4.1A) ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.69A	4qmnA-4f99A: 17.1	4qmnA-4f99A: 25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMS_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	9 / 11	ILE A 64 ALA A 88 LYS A 90 GLU A 104 ILE A 132 TYR A 136 LEU A 137 LEU A 184 ASP A 196	None ADP A 601 (-3.5A) ADP A 601 (-2.6A) None None ADP A 601 (-4.1A) None ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.84A	4qmsA-4f99A: 17.2	4qmsA-4f99A: 25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	8 / 12	ILE A 64 GLY A 65 VAL A 72 ALA A 88 MET A 134 TYR A 136 LEU A 137 LEU A 184	None ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A) ADP A 601 (-4.1A) None ADP A 601 ( 4.9A)	0.80A	4qmzA-4f99A: 17.2	4qmzA-4f99A: 25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U8V_B_MIYB1103_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	PHE A 404 GLY A 401 ASP A 551 ALA A 563 PHE A 569	None	1.02A	4u8vB-4f99A: undetectable	4u8vB-4f99A: 16.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	VAL A 72 ALA A 88 LYS A 90 ASP A 196 PHE A 197	ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) MG A 602 ( 3.1A) None	0.64A	4xv2A-4f99A: 15.8	4xv2A-4f99A: 24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 12	ALA A 88 LYS A 90 LEU A 108 ASP A 196 PHE A 197	ADP A 601 (-3.5A) ADP A 601 (-2.6A) None MG A 602 ( 3.1A) None	0.93A	4xv2B-4f99A: 15.8	4xv2B-4f99A: 24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_R_BEZR801_1 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens; Homo sapiens)	4 / 8	ALA B 319 HIS A 129 LEU B 310 LEU B 311	None	0.89A	5dzkd-4f99B: undetectable 5dzkr-4f99B: undetectable	5dzkd-4f99B: 19.16 5dzkr-4f99B: 1.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_B_032B401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	6 / 12	VAL A 72 ALA A 88 LYS A 90 ILE A 132 TYR A 136 PHE A 197	ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) None ADP A 601 (-4.1A) None	0.92A	5hesB-4f99A: 19.7	5hesB-4f99A: 23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGJ_A_CTYA402_2 (MACROLIDE 2'-PHOSPHOTRANSFERAS E)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 5	PRO A 554 LEU A 421 TYR A 415 PHE A 379	None	1.45A	5igjA-4f99A: 8.3	5igjA-4f99A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A 65 GLY A 67 VAL A 72 LYS A 90	ADP A 601 ( 3.8A) ADP A 601 (-3.7A) ADP A 601 (-4.0A) ADP A 601 (-2.6A)	0.35A	5izjA-4f99A: 22.1	5izjA-4f99A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A 65 GLY A 67 VAL A 72 LYS A 90	ADP A 601 ( 3.8A) ADP A 601 (-3.7A) ADP A 601 (-4.0A) ADP A 601 (-2.6A)	0.39A	5j5xA-4f99A: 17.0	5j5xA-4f99A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JMN_B_FUAB1101_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE PROTEIN DBF4 HOMOLOG A (Homo sapiens)	4 / 5	ILE B 330 LEU A 92 LYS A 90 VAL A 120	None None ADP A 601 (-2.6A) None	1.04A	5jmnB-4f99B: undetectable	5jmnB-4f99B: 8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	5 / 9	ILE A 64 GLY A 65 VAL A 72 ALA A 88 MET A 134	None ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 ( 3.9A)	0.50A	5lw1B-4f99A: 8.4	5lw1B-4f99A: 12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	7 / 12	ILE A 64 GLY A 65 VAL A 72 ALA A 88 LYS A 90 GLU A 104 TYR A 136	None ADP A 601 ( 3.8A) ADP A 601 (-4.0A) ADP A 601 (-3.5A) ADP A 601 (-2.6A) None ADP A 601 (-4.1A)	0.50A	5mafA-4f99A: 24.5	5mafA-4f99A: 13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OWR_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 8	ALA A 88 GLU A 104 LEU A 184 ASP A 196	ADP A 601 (-3.5A) None ADP A 601 ( 4.9A) MG A 602 ( 3.1A)	0.47A	5owrA-4f99A: 14.8	5owrA-4f99A: 25.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 6	PHE A 162 LEU A 165 ALA A 400 GLN A 170	None	1.01A	6b89B-4f99A: undetectable	6b89B-4f99A: 13.38

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1IE9_A_VDXA500_1","VITAMIN D3 RECEPTOR","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"LEU A 550;LEU A 546;SER A 406;SER A 409;CYH A 462","None","1.19A","1ie9A-4f99A:undetectable","1ie9A-4f99A:21.64"],["1IGX_A_EPAA700_1","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",5,"PHE A 414;PHE B 253;GLY A 432;ALA A 455;LEU A 461","None","0.90A","1igxA-4f99A:undetectable","1igxA-4f99A:19.90"],["1NH8_A_HISA289_0","ATP PHOSPHORIBOSYLTRANSFERASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"ASP A 177;LEU A 194;ALA A 200;LEU A 199","None","1.04A","1nh8A-4f99A:undetectable","1nh8A-4f99A:22.65"],["1QCA_A_FUAA221_1","TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"CYH A 462;PHE A 151;SER A 409;PHE A 404","None","1.14A","1qcaA-4f99A:undetectable","1qcaA-4f99A:19.79"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"ILE A  64;LYS A  90;LEU A 108;ILE A 173","None;ADP A 601 (-2.6A);None;None","0.88A","1uwjA-4f99A:5.1","1uwjA-4f99A:25.52"],["2EVA_A_ADNA498_1","TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"GLY A  65;VAL A  72;ALA A  88;MET A 134;TYR A 136;LEU A 184","ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);ADP A 601 (-4.1A);ADP A 601 ( 4.9A)","0.54A","2evaA-4f99A:21.8","2evaA-4f99A:24.02"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"GLY A  65;VAL A  72;ALA A  88;MET A 134;LYS A 179;ASN A 182;ASP A 196","ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);None; MG A 602 ( 2.6A); MG A 602 ( 3.1A)","0.81A","2fumB-4f99A:17.4","2fumB-4f99A:23.02"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"GLY A  65;VAL A  72;ALA A  88;MET A 134;TYR A 136;ASN A 182;ASP A 196","ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);ADP A 601 (-4.1A); MG A 602 ( 2.6A); MG A 602 ( 3.1A)","0.73A","2fumB-4f99A:17.4","2fumB-4f99A:23.02"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"GLY A  65;VAL A  72;ALA A  88;MET A 134;TYR A 136;ASN A 182","ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);ADP A 601 (-4.1A); MG A 602 ( 2.6A)","0.70A","2fumC-4f99A:16.1","2fumC-4f99A:23.02"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"GLY A  65;GLY A  67;VAL A  72;ALA A  88;MET A 134;LYS A 179;ASN A 182","ADP A 601 ( 3.8A);ADP A 601 (-3.7A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);None; MG A 602 ( 2.6A)","0.93A","2fumD-4f99A:16.0","2fumD-4f99A:23.02"],["2VN1_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE;70 KDA PEPTIDYLPROLYL ISOMERASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",4,"LEU A 550;SER B 251;PHE B 253;ASP B 254","None","0.99A","2vn1B-4f99A:undetectable","2vn1B-4f99A:15.67"],["2Y6O_A_1N1A1892_1","EPHRIN TYPE-A RECEPTOR 4","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"ILE A  64;ALA A  88;LYS A  90;GLU A 104;ILE A 132;TYR A 136;LEU A 184","None;ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;None;ADP A 601 (-4.1A);ADP A 601 ( 4.9A)","0.62A","2y6oA-4f99A:15.5","2y6oA-4f99A:23.86"],["2YY8_B_SAMB500_0","UPF0106 PROTEIN PH0461","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"HIS A 139;VAL A  72;GLY A  65;ILE A  87;ALA A  88","ADP A 601 (-4.0A);ADP A 601 (-4.0A);ADP A 601 ( 3.8A);None;ADP A 601 (-3.5A)","0.98A","2yy8A-4f99A:undetectable;2yy8B-4f99A:undetectable","2yy8A-4f99A:20.73;2yy8B-4f99A:20.73"],["3LD6_B_KKKB602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"PHE A 197;PHE A 569;PHE A 162;ILE A 403;MET A 397","None","1.47A","3ld6B-4f99A:undetectable","3ld6B-4f99A:22.03"],["3M7R_A_VDXA425_1","VITAMIN D3 RECEPTOR","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"LEU A 550;LEU A 546;SER A 406;SER A 409;CYH A 462","None","1.15A","3m7rA-4f99A:undetectable","3m7rA-4f99A:21.64"],["3OEZ_B_STIB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"VAL A  72;ALA A  88;LYS A  90;GLU A 104;ILE A 132;TYR A 136;LEU A 184","ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;None;ADP A 601 (-4.1A);ADP A 601 ( 4.9A)","0.72A","3oezB-4f99A:14.9","3oezB-4f99A:26.20"],["3SMT_A_ACTA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SETD3","4f99","PROTEIN DBF4 HOMOLOG A","Homo sapiens",3,"PHE B 318;SER B 321;GLN B 323","None","0.91A","3smtA-4f99B:undetectable","3smtA-4f99B:15.20"],["3T3Z_C_9PLC501_1","CYTOCHROME P450 2E1","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",4,"PHE A 124;PHE B 338;ALA A  77;LEU A  89","None","1.16A","3t3zC-4f99A:undetectable","3t3zC-4f99A:22.00"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"ILE A  64;GLY A  67;VAL A  72;ALA A  88;LYS A  90;ASP A 196","None;ADP A 601 (-3.7A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A); MG A 602 ( 3.1A)","0.61A","3v5wA-4f99A:7.4","3v5wA-4f99A:20.98"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"ILE A  64;VAL A  72;ALA A  88;LYS A  90;LEU A  92;ASP A 196","None;ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);None; MG A 602 ( 3.1A)","0.76A","3v5wA-4f99A:7.4","3v5wA-4f99A:20.98"],["4AGC_A_AXIA2000_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"VAL A  72;ALA A  88;LYS A  90;GLU A 104;LEU A 108;LEU A 184","ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;None;ADP A 601 ( 4.9A)","0.55A","4agcA-4f99A:13.7","4agcA-4f99A:22.34"],["4C8B_A_0LIA1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"ALA A  88;LYS A  90;GLU A 104;LEU A 108;ILE A 132;HIS A 175;LEU A 184","ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;None;None;None;ADP A 601 ( 4.9A)","0.63A","4c8bA-4f99A:14.0","4c8bA-4f99A:27.11"],["4E1G_A_LNLA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",5,"PHE A 414;PHE B 253;GLY A 432;ALA A 455;LEU A 461","None","0.91A","4e1gA-4f99A:undetectable","4e1gA-4f99A:20.33"],["4E1G_B_LNLB701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",5,"PHE A 414;PHE B 253;GLY A 432;ALA A 455;LEU A 461","None","0.92A","4e1gB-4f99A:undetectable","4e1gB-4f99A:20.33"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"VAL A  72;ALA A  88;LYS A  90;LEU A 184;ASP A 196","ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.57A","4iaaA-4f99A:23.8","4iaaA-4f99A:24.40"],["4M6T_A_SAMA201_0","RNA POLYMERASE II-ASSOCIATED FACTOR 1 HOMOLOG, LINKER, RNA POLYMERASE-ASSOCIATED PROTEIN LEO1","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"ILE A 168;VAL A 195;VAL A 117;ARG A 167","None","1.24A","4m6tA-4f99A:undetectable","4m6tA-4f99A:21.70"],["4OGR_A_ADNA401_1","CYCLIN-DEPENDENT KINASE 9","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"ILE A  64;VAL A  72;ALA A  88;ASN A 182;LEU A 184;ASP A 196","None;ADP A 601 (-4.0A);ADP A 601 (-3.5A); MG A 602 ( 2.6A);ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.53A","4ogrA-4f99A:22.1","4ogrA-4f99A:30.45"],["4OGR_E_ADNE401_1","CYCLIN-DEPENDENT KINASE 9","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"GLY A  65;ALA A  88;ASN A 182;LEU A 184;ASP A 196","ADP A 601 ( 3.8A);ADP A 601 (-3.5A); MG A 602 ( 2.6A);ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.72A","4ogrE-4f99A:17.7","4ogrE-4f99A:30.45"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"ILE A  64;VAL A  72;ALA A  88;ASN A 182;LEU A 184;ASP A 196","None;ADP A 601 (-4.0A);ADP A 601 (-3.5A); MG A 602 ( 2.6A);ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.58A","4ogrI-4f99A:24.5","4ogrI-4f99A:30.45"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"ILE A  64;ALA A  88;GLU A 104;ILE A 132;TYR A 136;LEU A 184;ASP A 196","None;ADP A 601 (-3.5A);None;None;ADP A 601 (-4.1A);ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.69A","4qmnA-4f99A:17.1","4qmnA-4f99A:25.19"],["4QMS_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",9,"ILE A  64;ALA A  88;LYS A  90;GLU A 104;ILE A 132;TYR A 136;LEU A 137;LEU A 184;ASP A 196","None;ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;None;ADP A 601 (-4.1A);None;ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.84A","4qmsA-4f99A:17.2","4qmsA-4f99A:25.19"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",8,"ILE A  64;GLY A  65;VAL A  72;ALA A  88;MET A 134;TYR A 136;LEU A 137;LEU A 184","None;ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A);ADP A 601 (-4.1A);None;ADP A 601 ( 4.9A)","0.80A","4qmzA-4f99A:17.2","4qmzA-4f99A:25.19"],["4U8V_B_MIYB1103_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"PHE A 404;GLY A 401;ASP A 551;ALA A 563;PHE A 569","None","1.02A","4u8vB-4f99A:undetectable","4u8vB-4f99A:16.82"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"VAL A  72;ALA A  88;LYS A  90;ASP A 196;PHE A 197","ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A); MG A 602 ( 3.1A);None","0.64A","4xv2A-4f99A:15.8","4xv2A-4f99A:24.74"],["4XV2_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"ALA A  88;LYS A  90;LEU A 108;ASP A 196;PHE A 197","ADP A 601 (-3.5A);ADP A 601 (-2.6A);None; MG A 602 ( 3.1A);None","0.93A","4xv2B-4f99A:15.8","4xv2B-4f99A:24.74"],["5DZK_R_BEZR801_1","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens;Homo sapiens",4,"ALA B 319;HIS A 129;LEU B 310;LEU B 311","None","0.89A","5dzkd-4f99B:undetectable;5dzkr-4f99B:undetectable","5dzkd-4f99B:19.16;5dzkr-4f99B:1.90"],["5HES_B_032B401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",6,"VAL A  72;ALA A  88;LYS A  90;ILE A 132;TYR A 136;PHE A 197","ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;ADP A 601 (-4.1A);None","0.92A","5hesB-4f99A:19.7","5hesB-4f99A:23.98"],["5IGJ_A_CTYA402_2","MACROLIDE 2'-PHOSPHOTRANSFERASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"PRO A 554;LEU A 421;TYR A 415;PHE A 379","None","1.45A","5igjA-4f99A:8.3","5igjA-4f99A:21.93"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"GLY A  65;GLY A  67;VAL A  72;LYS A  90","ADP A 601 ( 3.8A);ADP A 601 (-3.7A);ADP A 601 (-4.0A);ADP A 601 (-2.6A)","0.35A","5izjA-4f99A:22.1","5izjA-4f99A:26.68"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"GLY A  65;GLY A  67;VAL A  72;LYS A  90","ADP A 601 ( 3.8A);ADP A 601 (-3.7A);ADP A 601 (-4.0A);ADP A 601 (-2.6A)","0.39A","5j5xA-4f99A:17.0","5j5xA-4f99A:26.68"],["5JMN_B_FUAB1101_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE;PROTEIN DBF4 HOMOLOG A","Homo sapiens",4,"ILE B 330;LEU A  92;LYS A  90;VAL A 120","None;None;ADP A 601 (-2.6A);None","1.04A","5jmnB-4f99B:undetectable","5jmnB-4f99B:8.98"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",5,"ILE A  64;GLY A  65;VAL A  72;ALA A  88;MET A 134","None;ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 ( 3.9A)","0.50A","5lw1B-4f99A:8.4","5lw1B-4f99A:12.68"],["5MAF_A_XINA403_1","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",7,"ILE A  64;GLY A  65;VAL A  72;ALA A  88;LYS A  90;GLU A 104;TYR A 136","None;ADP A 601 ( 3.8A);ADP A 601 (-4.0A);ADP A 601 (-3.5A);ADP A 601 (-2.6A);None;ADP A 601 (-4.1A)","0.50A","5mafA-4f99A:24.5","5mafA-4f99A:13.01"],["5OWR_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 10","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"ALA A  88;GLU A 104;LEU A 184;ASP A 196","ADP A 601 (-3.5A);None;ADP A 601 ( 4.9A); MG A 602 ( 3.1A)","0.47A","5owrA-4f99A:14.8","5owrA-4f99A:25.71"],["6B89_A_NOVA403_2","LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB;LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB","4f99","CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE","Homo sapiens",4,"PHE A 162;LEU A 165;ALA A 400;GLN A 170","None","1.01A","6b89B-4f99A:undetectable","6b89B-4f99A:13.38"]]